Heidelberg clinic first in Germany to offer TomoTherapy radiotherapy
22 August 2006
Madiaon, Wis. USA. TomoTherapy Incorporated has announced that
the University Clinic Heidelberg is the first German institution
to treat cancer patients with the TomoTherapy Hi-Art System.
"The University Clinic Heidelberg is very proud to be the first
centre in Germany which can offer the new TomoTherapy treatment
to its patients," said Prof. Dr. Jurgen Debus, Medical Director
of the Clinic's Department of Radiooncology and Radiation
Therapy. "It is a perfect addition to our concept in Heidelberg,
which ranges from IMRT, stereotaxy and radiosurgery to proton
and heavy ion treatments.
"The novel combination of CT and linear accelerator technology brings
new possibilities to improve the precision of radiation therapy and
allows us to treat cases which have been very difficult to treat with
standard linear accelerators."
Dr. Gabriele Sroka-Perez, Head of Medical Physics for the Department,
explained, "It was a challenge for our team to install and commission
the first TomoTherapy Hi-Art System in Germany. The innovative
technology used in the System required new approaches for the
commissioning and approval process. Our expectations for the performance
and stability of the TomoTherapy System were more than fulfilled."
Dr. Fred Robertson, CEO of TomoTherapy Inc. said, "We are pleased to
share this milestone with the University Clinic Heidelberg, and with
patients throughout the region. We look forward to the coming months,
when we'll install four more Hi-Art Systems in Germany."
Additional German sites to receive TomoTherapy Hi-Art Systems include
Charite Berlin, the University Clinic Essen, the Clinic of the Technical
University Munich Rechts der Isar and the University Clinic Hamburg.